Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-020-0 | CAS number: 191680-81-6 CGL 116
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The LD50 values in rats for acute oral exposure and in rabbits for acute dermal exposure to the test substance are >5000 mg/kg bw and >2000 mg/kg bw, respectively.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: guideline study in compliance with GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.1175 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ace Animals, Boyertown, PA
- Age at study initiation: about 6 - 9 weeks
- Weight at study initiation: 210-241 grams for males and 200-230 grams for females
- Fasting period before study: 16 - 20 hours
- Housing: 5/sex/cage in suspended wire cages. Bedding was placed beneath the cages and changed at least three times/week.
- Diet: Fresh Purina Rat Chow (Diet #5012) was freely available
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: controlled
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route of administration:
- oral: gavage
- Vehicle:
- other: 0.2% methyl cellulose
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 33%
DOSAGE PREPARATION (if unusual):
The test article was mixed with 0.2% methyl cellulose to make dosing by gavage possible. The dose was based on the dry weight of the test article. - Doses:
- 5000 mg/kg body weight
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed 1,2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects. The animals were observed twice daily for mortality. Body weights were recorded immediately pretest, on days 3 and 7. at death or at termination in the survivors.
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals survived the 5000 mg/kg oral dose.
- Clinical signs:
- other: There were no abnormal systemic signs noted in 9/10 animals. One female had dyspnea, lethargy, emaciation, ataxia and weight loss throughout the study period.
- Gross pathology:
- Necropsy results were normal in 9/10 animals. Necropsy observation of animal #10-F revealed that the weight loss and abnormal systemic signs were due to a dosing error rather than to an effect of the test article.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information
- Conclusions:
- Based on the results of this study, the oral LD50 in rats is greater than 5000 mg/kg.
- Executive summary:
In a GLP compliant OECD guideline study, 5 male and 5 female Wistar rats were treated with the test substance by oral gavage administration at a dosage of 5000 mg/kg body weight. The test item was used as a 33% mixture in 0.2 % methyl cellulose. All animals were observed 1, 2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects. The animals were observed twice daily for mortality. Body weights were recorded immediately pretest, on days 3 and 7and at termination of the study. All animals were necropsied and examined macroscopically. All animals survived until the end of the study period. Instances of transient weight loss were noted in two females. All other animals gained weight normally. There were no abnormal systemic signs noted in 9/10 animals. One female (#10) had dyspnea, lethargy, emaciation, ataxia and weight loss throughout the study period. Necropsy results were normal in 9/10 animals. Necropsy observation of animal #10-F revealed that the weight loss and abnormal systemic signs were due to a dosing error rather than to an effect of the test article. Therefore, the LD50 in the rat was determined to exceed 5000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline Study performed under GLP like quality controlled conditions.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.1100 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- GLP compliance:
- no
- Remarks:
- QAU statement included
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ace Animals, Boyertown, PA
- Age at study initiation: 2-4 months
- Weight at study initiation: 2.0 - 2.4 kg
- Fasting period before study:
- Housing: 1/cage in suspended wire cages. Bedding was placed beneath the cages and changed at least three times per week.
- Diet: Fresh Purina Rabbit Chow (Diet #5321) was provided daily.
- Water: ad libitum
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature: controlled
- Photoperiod (hrs dark / hrs light): 12 / 12 - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- The patch and test article were moistened with saline to enhance contact of the test article with the dose site.
- Details on dermal exposure:
- TEST SITE
- Area of exposure: trunk
- % coverage: 10% of the body surface
- Type of wrap if used: The test article was applied under a 4 layered surgical gauze patch measuring 10 x 15 cm. The torso was wrapped with plastic which was secured with nonirritating tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Residual test article was removed by gentle washing with distilled water.
- Time after start of exposure: 24 hours - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed 1,2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects. The animals were observed twice daily for 14 days for mortality. Body weights were recorded pretest and on days 3,7 and 14 or at death.
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals survived the 2000 mg/kg dermal application.
- Clinical signs:
- other: Instances of mucoid diarrhea, diarrhea and anogenital soiling were the only abnormal systemic signs noted during the study.
- Gross pathology:
- Necropsy results were normal in 8/10 animals. Soiling of the anogenital area was noted in one animal and lung abnormalities in another.
- Other findings:
- Dermal Observations: There were no abnormal dermal responses at any observation period up to and including 72 hours. Thereafter, observations were discontinued.
- Conclusions:
- Based on this study, the dermal LD50 in rabbits was determined to exceed 2000 mg/kg.
- Executive summary:
In an acute dermal toxicity study following OECD guideline 402, 5 male and 5 female New Zealand White rabbits were dermally exposed to the test item for 24 hours at a limit dose of 2000 mg/kg body weight. The test article was moistened with saline and applied to the clipped trunk of the animals under a 4 layered surgical gauze patch measuring 10 x 15 cm. The torso was wrapped with plastic which was secured with nonirritating tape. After 24 hours the wrapping was removed and residual test article was washed off with distilled water. All animals were observed 1, 2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects. The animals were observed twice daily for 14 days for mortality. Body weights were recorded pretest and on days 3, 7 and 14 or at death. All animals were examined for gross pathology. All animals survived the 2000 mg/kg dermal application. Body weight changes were normal in 8/10 animals. Two animals lost weight during the second week of the observation period. There were no abnormal dermal responses at any observation period up to and including 72 hours. Thereafter, observations were discontinued. Instances of mucoid diarrhea and diarrhea were the only abnormal systemic signs noted during the study. Necropsy results were normal in 8/10 animals. Soiling of the anogenital area was noted in one animal and lung abnormalities in another. Based on these observations, the dermal LD50 value of the test item was greater than 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute oral toxicity
The acute oral toxicity of the test substance was assessed in a GLP-compliant study following OECD guideline 401 (MB Research Labs, MB 97-5875.01, 1997). In the limit test, a single dose of 5000 mg/kg bw in 0.2% methyl cellulose was applied by gavage to five male and five female Wistar rats followed by an observation period of 14 days. No mortalities were recorded. Instances of transient weight loss were noted in two females, all other animals gained weight normally. No clinical signs were recorded except in one female (#10) which suffered from dyspnea, lethargy, emaciation, ataxia and weight loss. Necropsy observation of animal #10 revealed that the weight loss and abnormal systemic signs were due to a dosing error rather than to an effect of the test article. No other abnormalities were noted for the other animals during necropsy. Overall, under the chosen test conditions, the test substance was not toxic after single oral administration: Oral LD50 > 5000 mg/kg bw
Acute dermal toxicity
An acute dermal toxicity study was performed according to OECD guideline No. 402 with 5 male and 5 female New Zealand White rabbits (MB Research Labs, MB 97 -5706.02, 1997). In the limit test, the test article was applied occlusively to the trunk of the test animals for 24 hours at a dose level of 2000 mg/kg body weight followed by an observation period of 14 days. No mortality occurred within the timeframe of the study. Instances of mucoid diarrhea and diarrhea were the only abnormal systemic signs noted during the study. There were no abnormal dermal responses at any observation period, up to and including 72 hours. Body weight changes were normal in 8/10 animals. Two animals lost weight during the second week of the observation period. Necropsy results were normal in 8/10 animals, soiling of the anogenital area was noted in one animal and lung abnormalities in another. Overall, under the chosen test conditions, the test substance does not have toxic properties in case of single dermal exposure: Dermal LD50 > 2000 mg/kg bw
Acute inhalation toxicity
No data available.
Justification for selection of acute toxicity – oral endpoint
guideline study in compliance with GLP
Justification for selection of acute toxicity – dermal endpoint
Guideline Study performed under GLP like quality controlled conditions.
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for the purpose of classification under Regulation (EC) No.1272/2008. Based on the data, classification for acute toxicity is not warranted under Regulation (EC) No.1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.